Joint Formulary & PAD

Citalopram - Depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Oral drops
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)

PAD Profile

ChemicalSubstance :
Citalopram
Indication :
Depression
Group Name :
Keywords :
SSRIs, selective serotonin re-uptake inhibitors, antidepressants
Brand Names Include :
Cipramil
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Citalopram is used to treat.

Committee Recommendations (1)

GENERIC Citalopram has been considered by the PCN and has been assigned a GREEN traffic light status. NOTE - the branded product, Cipramil, was considered BLACK at the PCN in May 2017. NOTE - The Mood Hive and associated local depression and anxiety treatment guidelines have been removed from PAD. Updated guidelines and resources for treating and managing depression in adults are being developed by Surrey & Borders Partnership. For current advice, in line with NICE guidance, please see the link to the Clinical Knowledge Summaries